Paying users zone. Data is hidden behind: .
Get 1-month access to Regeneron Pharmaceuticals Inc. for $13.99, or
get full access to the entire website for at least 3 months from $49.99.
This is a one-time payment. There is no automatic renewal.
Regeneron Pharmaceuticals Inc. pages available today for free:
Statement of Comprehensive Income
Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
Regeneron Pharmaceuticals Inc., consolidated statement of comprehensive income
US$ in thousands
|12 months ended:||Dec 31, 2020||Dec 31, 2019||Dec 31, 2018||Dec 31, 2017||Dec 31, 2016|
|Unrealized gain (loss) on debt securities|
|Unrealized gain (loss) on cash flow hedges|
|Other comprehensive income (loss), net of tax|
|Comprehensive income item||Description||The company|
|Net income||The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.||Regeneron Pharmaceuticals Inc.’s net income decreased from 2018 to 2019 but then increased from 2019 to 2020 exceeding 2018 level.|
|Comprehensive income||Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.||Regeneron Pharmaceuticals Inc.’s comprehensive income decreased from 2018 to 2019 but then increased from 2019 to 2020 exceeding 2018 level.|